Word

X-FAST

Status

Dead

Status Code

606

Status Date

Monday, December 19, 2022

Serial Number

88299280

Mark Type

4000

Filing Date

Wednesday, February 13, 2019

Published for Opposition

Tuesday, July 9, 2019

Abandoned Date

Monday, December 19, 2022

Trademark Owner History

Essenlix Corporation - Owner At Publication

Classifications

5 Medical diagnostic reagents and assays for testing of body fluids; Medical diagnostic reagents and assays for testing cells, proteins, small molecules, nucleotides, and nucleic acids; Medical diagnostic reagents; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, cancers, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, and genetic diseases; Diagnostic biomarker reagents for medical purposes; all the foregoing employing the staining of biological samples

1 Assays for research purposes; Biological and chemical reagents used for non-medical purposes, in vitro and in vivo scientific use, the testing of bodily fluids, and the detecting and analyzing of cells, proteins, small molecules, and nucleotides; Biological and chemical test kits for laboratory or research use in the field of personal wellness; Biological and chemical test kits for laboratory or research use for the detection and identification of nucleic acids, namely, DNA and RNA in a sample; all the foregoing employing the staining of biological samples

44 Medical services; Medical assistance; Medical consultations; Medical counseling; Medical information; Healthcare services; diagnostic services, namely, medical testing for diagnostic purposes; Wellness services, namely, providing mental health and wellness information; Medical services, medical assistance, medical consultations, medical counseling, medical information, healthcare testing, diagnostic testing, and wellness services, all in the fields of cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, genetic diseases, and other tissue-based diagnostic testing, cytology, and cell-based testing; Medical testing services for the detection and identification of cells, proteins, small molecules, and nucleic acids in a sample, all the foregoing employing the staining of biological samples

10 Medical diagnostic apparatus for testing cells, tissue, biomolecules, proteins, small molecules, and nucleotides; Medical devices for obtaining bodily fluid samples; Medical diagnostic instruments for the analysis of bodily fluids; Medical apparatus for diagnostic use, namely, medical apparatus for diagnostic testing of health conditions, diseases, or abnormalities, in the fields of cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, genetic diseases, and endocrine diseases, and other tissue-based diagnostic testing, cytology, and cell based testing; Medical apparatus, devices, and instruments for wellness testing, health condition testing, and healthcare testing, namely, point-of-care diagnostic devices, at-home diagnostic devices, and portable health monitoring devices that detect health conditions and diseases in the nature of cancers, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases and genetic diseases; Medical apparatus, devices, and instruments for the detection and identification of nucleic acids, namely, DNA and RNA in a sample; all the foregoing employing the staining of biological samples

Trademark Events

Dec 19, 2022

Abandonment Notice E-Mailed - No Use Statement Filed

Dec 19, 2022

Abandonment - No Use Statement Filed

May 17, 2022

Noa E-Mailed - Sou Required From Applicant

Apr 6, 2022

Ttab Release Case To Trademarks

Apr 6, 2022

Opposition Terminated No. 999999

Apr 6, 2022

Opposition Dismissed No. 999999

Sep 9, 2019

Opposition Instituted No. 999999

Jul 29, 2019

Extension Of Time To Oppose Received

Jul 9, 2019

Official Gazette Publication Confirmation E-Mailed

Jul 9, 2019

Published For Opposition

Jun 19, 2019

Notification Of Notice Of Publication E-Mailed

May 31, 2019

Assigned To Lie

May 17, 2019

Approved For Pub - Principal Register

May 17, 2019

Examiner's Amendment Entered

May 17, 2019

Notification Of Examiners Amendment E-Mailed

May 17, 2019

Examiners Amendment E-Mailed

May 17, 2019

Examiners Amendment -Written

Mar 28, 2019

Notification Of Priority Action E-Mailed

Mar 28, 2019

Priority Action E-Mailed

Mar 28, 2019

Priority Action Written

Mar 22, 2019

Assigned To Examiner

Mar 6, 2019

New Application Office Supplied Data Entered

Feb 16, 2019

New Application Entered